$RGEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REPLIGEN CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REPLIGEN CORP. Get notifications about new insider transactions in REPLIGEN CORP for free.
Page: < prev 1 2 3 4 5 6 7 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 01 2016 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Grant | A | 0.00 | 33,589 | 0 | 77,231 | 43.6 K to 77.2 K (+76.96 %) |
Nov 20 2015 | RGEN | REPLIGEN CORP | Benjamin Howard | Option Exercise | M | 3.33 | 5,000 | 16,650 | 0 | ||
Nov 20 2015 | RGEN | REPLIGEN CORP | Benjamin Howard | Buy | M | 3.33 | 5,000 | 16,650 | 16,554 | 11.6 K to 16.6 K (+43.28 %) | |
Nov 12 2015 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Grant | A | 26.56 | 1,000 | 26,564 | 35,331 | 34.3 K to 35.3 K (+2.91 %) |
Nov 12 2015 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Grant | A | 26.70 | 1,000 | 26,700 | 40,241 | 39.2 K to 40.2 K (+2.55 %) |
Nov 12 2015 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Payment of Exercise | F | 38.46 | 1,625 | 62,498 | 43,642 | 45.3 K to 43.6 K (-3.59 %) |
Nov 12 2015 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Payment of Exercise | F | 41.30 | 325 | 13,423 | 10,620 | 10.9 K to 10.6 K (-2.97 %) |
Sep 16 2015 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Option Exercise | A | 36.29 | 24,000 | 870,960 | 24,000 | |
Jun 10 2015 | RGEN | REPLIGEN CORP | Benjamin Howard | Sell | S | 37.48 | 7,697 | 288,486 | 11,554 | 19.3 K to 11.6 K (-39.98 %) | |
Jun 10 2015 | RGEN | REPLIGEN CORP | Benjamin Howard | Sell | S | 38.32 | 27,303 | 1,046,368 | 19,251 | 46.6 K to 19.3 K (-58.65 %) | |
Jun 02 2015 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Gift | G | 0.00 | 1,000 | 0 | 20,331 | 21.3 K to 20.3 K (-4.69 %) |
May 26 2015 | RGEN | REPLIGEN CORP | Goldberg Alfred Lewis | Director | Option Exercise | A | 41.19 | 1,992 | 82,050 | 1,992 | |
May 26 2015 | RGEN | REPLIGEN CORP | Goldberg Alfred Lewis | Director | Grant | A | 0.00 | 1,019 | 0 | 40,331 | 39.3 K to 40.3 K (+2.59 %) |
May 26 2015 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Option Exercise | A | 41.19 | 2,929 | 120,646 | 2,929 | |
May 26 2015 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Grant | A | 0.00 | 1,498 | 0 | 39,241 | 37.7 K to 39.2 K (+3.97 %) |
May 26 2015 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | A | 41.19 | 3,632 | 149,602 | 3,632 | |
May 26 2015 | RGEN | REPLIGEN CORP | Cox John | Director | Grant | A | 0.00 | 1,858 | 0 | 1,858 | 0 to 1.9 K |
May 26 2015 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | A | 41.19 | 1,992 | 82,050 | 1,992 | |
May 26 2015 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Grant | A | 0.00 | 1,019 | 0 | 34,331 | 33.3 K to 34.3 K (+3.06 %) |
May 26 2015 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | A | 41.19 | 1,992 | 82,050 | 1,992 | |
May 26 2015 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Grant | A | 0.00 | 1,019 | 0 | 1,019 | 0 to 1 K |
May 26 2015 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 41.19 | 1,992 | 82,050 | 1,992 | |
May 26 2015 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Grant | A | 0.00 | 1,019 | 0 | 21,331 | 20.3 K to 21.3 K (+5.02 %) |
May 19 2015 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Sell | S | 41.32 | 15,000 | 619,833 | 96,849 | 111.8 K to 96.8 K (-13.41 %) |
May 14 2015 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Sell | S | 38.97 | 45,431 | 1,770,332 | 262,430 | 307.9 K to 262.4 K (-14.76 %) |
May 12 2015 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Gift | G | 0.00 | 10,000 | 0 | 307,861 | 317.9 K to 307.9 K (-3.15 %) |
May 12 2015 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Sell | S | 38.68 | 35,715 | 1,381,610 | 317,861 | 353.6 K to 317.9 K (-10.10 %) |
May 12 2015 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Sell | S | 37.55 | 68,854 | 2,585,468 | 353,576 | 422.4 K to 353.6 K (-16.30 %) |
May 12 2015 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 37.19 | 20,000 | 743,800 | 20,312 | 40.3 K to 20.3 K (-49.61 %) |
Mar 25 2015 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Sell | S | 33.30 | 14,650 | 487,845 | 111,849 | 126.5 K to 111.8 K (-11.58 %) |
Mar 23 2015 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT AND CEO | Sell | S | 31.76 | 23,686 | 752,173 | 422,430 | 446.1 K to 422.4 K (-5.31 %) |
Mar 23 2015 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT AND CEO | Sell | S | 32.51 | 850 | 27,629 | 446,116 | 447 K to 446.1 K (-0.19 %) |
Mar 20 2015 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT AND CEO | Sell | S | 33.08 | 49,695 | 1,643,762 | 446,966 | 496.7 K to 447 K (-10.01 %) |
Mar 20 2015 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 32.62 | 10,000 | 326,187 | 40,312 | 50.3 K to 40.3 K (-19.88 %) |
Mar 19 2015 | RGEN | REPLIGEN CORP | Benjamin Howard | Option Exercise | M | 15.91 | 3,807 | 60,569 | 7,614 | ||
Mar 19 2015 | RGEN | REPLIGEN CORP | Benjamin Howard | Option Exercise | M | 6.23 | 10,000 | 62,300 | 20,000 | ||
Mar 19 2015 | RGEN | REPLIGEN CORP | Benjamin Howard | Sell | S | 32.63 | 15,795 | 515,443 | 46,554 | 62.3 K to 46.6 K (-25.33 %) | |
Mar 19 2015 | RGEN | REPLIGEN CORP | Benjamin Howard | Buy | M | 15.91 | 3,807 | 60,569 | 62,349 | 58.5 K to 62.3 K (+6.50 %) | |
Mar 19 2015 | RGEN | REPLIGEN CORP | Benjamin Howard | Buy | M | 6.23 | 10,000 | 62,300 | 58,542 | 48.5 K to 58.5 K (+20.60 %) | |
Mar 02 2015 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Operating Off ... | Option Exercise | A | 24.98 | 39,037 | 975,144 | 39,037 | |
Mar 02 2015 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Operating Off ... | Grant | A | 0.00 | 20,267 | 0 | 45,267 | 25 K to 45.3 K (+81.07 %) |
Mar 02 2015 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | A | 24.98 | 11,445 | 285,896 | 11,445 | |
Mar 02 2015 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Grant | A | 0.00 | 5,945 | 0 | 10,945 | 5 K to 10.9 K (+118.90 %) |
Mar 02 2015 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Option Exercise | A | 24.98 | 10,067 | 251,474 | 10,067 | |
Mar 02 2015 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Grant | A | 0.00 | 5,229 | 0 | 126,499 | 121.3 K to 126.5 K (+4.31 %) |
Mar 02 2015 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | A | 24.98 | 9,031 | 225,594 | 9,031 | |
Mar 02 2015 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Grant | A | 0.00 | 4,691 | 0 | 48,542 | 43.9 K to 48.5 K (+10.70 %) |
Nov 20 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Sell | S | 22.95 | 4,158 | 95,426 | 496,661 | 500.8 K to 496.7 K (-0.83 %) |
Nov 20 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Sell | S | 23.47 | 47,228 | 1,108,441 | 500,819 | 548 K to 500.8 K (-8.62 %) |
Nov 18 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Option Exercise | M | 3.33 | 10,000 | 33,300 | 10,000 | |
Nov 18 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Payment of Exercise | F | 23.30 | 1,430 | 33,319 | 548,047 | 549.5 K to 548 K (-0.26 %) |
Nov 18 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Buy | M | 3.33 | 10,000 | 33,300 | 549,477 | 539.5 K to 549.5 K (+1.85 %) |
Nov 17 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 3.30 | 10,000 | 33,000 | 5,000 | |
Nov 17 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 23.81 | 10,000 | 238,100 | 50,312 | 60.3 K to 50.3 K (-16.58 %) |
Nov 17 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 3.30 | 10,000 | 33,000 | 60,312 | 50.3 K to 60.3 K (+19.88 %) |
Nov 12 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Sell | S | 23.56 | 30,000 | 706,800 | 43,851 | 73.9 K to 43.9 K (-40.62 %) |
Nov 12 2014 | RGEN | REPLIGEN CORP | GRIFFITH MICHAEL A | Director | Option Exercise | M | 4.53 | 16,000 | 72,480 | 8,000 | |
Nov 12 2014 | RGEN | REPLIGEN CORP | GRIFFITH MICHAEL A | Director | Sell | S | 22.92 | 16,000 | 366,720 | 1,932 | 17.9 K to 1.9 K (-89.23 %) |
Nov 12 2014 | RGEN | REPLIGEN CORP | GRIFFITH MICHAEL A | Director | Sell | S | 22.86 | 7,342 | 167,838 | 17,932 | 25.3 K to 17.9 K (-29.05 %) |
Nov 12 2014 | RGEN | REPLIGEN CORP | GRIFFITH MICHAEL A | Director | Buy | M | 4.53 | 16,000 | 72,480 | 25,274 | 9.3 K to 25.3 K (+172.53 %) |
Aug 14 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 3.33 | 5,000 | 16,650 | 5,000 | |
Aug 14 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Sell | S | 20.34 | 40,000 | 813,792 | 73,851 | 113.9 K to 73.9 K (-35.13 %) |
Aug 14 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 3.33 | 5,000 | 16,650 | 113,851 | 108.9 K to 113.9 K (+4.59 %) |
Jul 15 2014 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Option Exercise | A | 24.50 | 10,000 | 245,000 | 10,000 | |
Jul 15 2014 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Jul 01 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 3.30 | 5,000 | 16,500 | 15,000 | |
Jul 01 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 4.96 | 5,000 | 24,800 | 0 | |
Jul 01 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 22.41 | 5,000 | 112,065 | 50,312 | 55.3 K to 50.3 K (-9.04 %) |
Jul 01 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 3.30 | 5,000 | 16,500 | 55,312 | 50.3 K to 55.3 K (+9.94 %) |
Jul 01 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 22.41 | 5,000 | 112,065 | 50,312 | 55.3 K to 50.3 K (-9.04 %) |
Jul 01 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 4.96 | 5,000 | 24,800 | 55,312 | 50.3 K to 55.3 K (+9.94 %) |
Jun 25 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 4.96 | 10,000 | 49,600 | 5,000 | |
Jun 25 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 21.78 | 10,000 | 217,780 | 50,312 | 60.3 K to 50.3 K (-16.58 %) |
Jun 25 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 4.96 | 10,000 | 49,600 | 60,312 | 50.3 K to 60.3 K (+19.88 %) |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Option Exercise | M | 6.23 | 10,000 | 62,300 | 30,000 | |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Option Exercise | M | 3.33 | 15,000 | 49,950 | 10,000 | |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Option Exercise | M | 5.87 | 50,000 | 293,500 | 0 | |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Option Exercise | M | 1.83 | 12,500 | 22,875 | 0 | |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Payment of Exercise | F | 21.98 | 2,834 | 62,291 | 77,999 | 80.8 K to 78 K (-3.51 %) |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Buy | M | 6.23 | 10,000 | 62,300 | 80,833 | 70.8 K to 80.8 K (+14.12 %) |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Payment of Exercise | F | 21.98 | 2,273 | 49,961 | 70,833 | 73.1 K to 70.8 K (-3.11 %) |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Buy | M | 3.33 | 15,000 | 49,950 | 73,106 | 58.1 K to 73.1 K (+25.81 %) |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Payment of Exercise | F | 21.98 | 13,353 | 293,499 | 58,106 | 71.5 K to 58.1 K (-18.69 %) |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Buy | M | 5.87 | 50,000 | 293,500 | 71,459 | 21.5 K to 71.5 K (+233.00 %) |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Payment of Exercise | F | 21.98 | 1,041 | 22,881 | 21,459 | 22.5 K to 21.5 K (-4.63 %) |
Jun 24 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Buy | M | 1.83 | 12,500 | 22,875 | 22,500 | 10 K to 22.5 K (+125.00 %) |
Jun 12 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Sell | S | 20.11 | 60,335 | 1,213,584 | 539,477 | 599.8 K to 539.5 K (-10.06 %) |
Jun 12 2014 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | A | 20.37 | 24,000 | 488,880 | 24,000 | |
Jun 10 2014 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Sell | S | 20.19 | 30,000 | 605,730 | 121,270 | 151.3 K to 121.3 K (-19.83 %) |
Jun 10 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Option Exercise | M | 6.23 | 21,250 | 132,388 | 63,750 | |
Jun 10 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Option Exercise | M | 3.33 | 10,000 | 33,300 | 20,000 | |
Jun 10 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Option Exercise | M | 5.87 | 20,000 | 117,400 | 0 | |
Jun 10 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Payment of Exercise | F | 20.41 | 6,486 | 132,379 | 599,812 | 606.3 K to 599.8 K (-1.07 %) |
Jun 10 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Buy | M | 6.23 | 21,250 | 132,388 | 606,298 | 585 K to 606.3 K (+3.63 %) |
Jun 10 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Payment of Exercise | F | 20.41 | 1,632 | 33,309 | 585,048 | 586.7 K to 585 K (-0.28 %) |
Jun 10 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Buy | M | 3.33 | 10,000 | 33,300 | 586,680 | 576.7 K to 586.7 K (+1.73 %) |
Jun 10 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Payment of Exercise | F | 20.41 | 5,752 | 117,398 | 576,680 | 582.4 K to 576.7 K (-0.99 %) |
Jun 10 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Buy | M | 5.87 | 20,000 | 117,400 | 582,432 | 562.4 K to 582.4 K (+3.56 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 4.96 | 5,000 | 24,800 | 15,000 | |
Jun 09 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 5.08 | 20,000 | 101,600 | 0 | |
Jun 09 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 4.29 | 20,000 | 85,800 | 0 | |
Jun 09 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 20.56 | 5,000 | 102,788 | 50,312 | 55.3 K to 50.3 K (-9.04 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 4.96 | 5,000 | 24,800 | 55,312 | 50.3 K to 55.3 K (+9.94 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 20.56 | 20,000 | 411,150 | 50,312 | 70.3 K to 50.3 K (-28.44 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 5.08 | 20,000 | 101,600 | 70,312 | 50.3 K to 70.3 K (+39.75 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 20.56 | 20,000 | 411,150 | 50,312 | 70.3 K to 50.3 K (-28.44 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 4.29 | 20,000 | 85,800 | 70,312 | 50.3 K to 70.3 K (+39.75 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Sell | S | 20.56 | 47,709 | 980,706 | 10,000 | 57.7 K to 10 K (-82.67 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 6.23 | 10,000 | 62,300 | 30,000 | |
Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 3.33 | 5,000 | 16,650 | 10,000 | |
Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 4.25 | 87,036 | 369,903 | 0 | |
Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Payment of Exercise | F | 20.30 | 3,069 | 62,301 | 108,851 | 111.9 K to 108.9 K (-2.74 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 6.23 | 10,000 | 62,300 | 111,920 | 101.9 K to 111.9 K (+9.81 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Payment of Exercise | F | 20.30 | 820 | 16,646 | 101,920 | 102.7 K to 101.9 K (-0.80 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 3.33 | 5,000 | 16,650 | 102,740 | 97.7 K to 102.7 K (+5.12 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Payment of Exercise | F | 20.30 | 18,222 | 369,907 | 97,740 | 116 K to 97.7 K (-15.71 %) |
Jun 09 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 4.25 | 87,036 | 369,903 | 115,962 | 28.9 K to 116 K (+300.89 %) |
May 19 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 18.12 | 3,696 | 66,972 | 3,696 | |
May 19 2014 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Grant | A | 0.00 | 1,932 | 0 | 50,312 | 48.4 K to 50.3 K (+3.99 %) |
May 19 2014 | RGEN | REPLIGEN CORP | GRIFFITH MICHAEL A | Director | Option Exercise | A | 18.12 | 3,696 | 66,972 | 3,696 | |
May 19 2014 | RGEN | REPLIGEN CORP | GRIFFITH MICHAEL A | Director | Grant | A | 0.00 | 1,932 | 0 | 9,274 | 7.3 K to 9.3 K (+26.31 %) |
May 19 2014 | RGEN | REPLIGEN CORP | Goldberg Alfred Lewis | Director | Option Exercise | A | 18.12 | 3,696 | 66,972 | 3,696 | |
May 19 2014 | RGEN | REPLIGEN CORP | Goldberg Alfred Lewis | Director | Grant | A | 0.00 | 1,932 | 0 | 39,312 | 37.4 K to 39.3 K (+5.17 %) |
May 19 2014 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Option Exercise | A | 18.12 | 7,392 | 133,943 | 7,392 | |
May 19 2014 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Grant | A | 0.00 | 3,863 | 0 | 37,743 | 33.9 K to 37.7 K (+11.40 %) |
May 19 2014 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | A | 18.12 | 3,696 | 66,972 | 3,696 | |
May 19 2014 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Grant | A | 0.00 | 1,932 | 0 | 33,312 | 31.4 K to 33.3 K (+6.16 %) |
May 06 2014 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Operating Off ... | Option Exercise | A | 16.55 | 50,000 | 827,500 | 50,000 | |
May 06 2014 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Operating Off ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Apr 15 2014 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Option Exercise | M | 3.05 | 25,000 | 76,250 | 0 | |
Apr 15 2014 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Buy | P | 3.05 | 25,000 | 76,250 | 151,270 | 126.3 K to 151.3 K (+19.80 %) |
Apr 15 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Option Exercise | M | 3.05 | 10,000 | 30,500 | 0 | |
Apr 15 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Buy | P | 3.05 | 10,000 | 30,500 | 57,709 | 47.7 K to 57.7 K (+20.96 %) |
Mar 03 2014 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Option Exercise | A | 15.91 | 12,727 | 202,487 | 12,727 | |
Mar 03 2014 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Grant | A | 0.00 | 6,644 | 0 | 143,914 | 137.3 K to 143.9 K (+4.84 %) |
Mar 03 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Option Exercise | A | 15.91 | 11,842 | 188,406 | 11,842 | |
Mar 03 2014 | RGEN | REPLIGEN CORP | WITT DANIEL P | Senior Vice Preside ... | Grant | A | 0.00 | 6,182 | 0 | 53,891 | 47.7 K to 53.9 K (+12.96 %) |
Mar 03 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | A | 15.91 | 11,421 | 181,708 | 11,421 | |
Mar 03 2014 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Grant | A | 0.00 | 5,962 | 0 | 28,926 | 23 K to 28.9 K (+25.96 %) |
Mar 03 2014 | RGEN | REPLIGEN CORP | Kelly William J | Chief Accounting Of ... | Option Exercise | A | 15.91 | 10,451 | 166,275 | 10,451 | |
Mar 03 2014 | RGEN | REPLIGEN CORP | Kelly William J | Chief Accounting Of ... | Grant | A | 0.00 | 5,456 | 0 | 5,456 | 0 to 5.5 K |
Mar 03 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Option Exercise | A | 15.91 | 47,200 | 750,952 | 47,200 | |
Mar 03 2014 | RGEN | REPLIGEN CORP | HERLIHY WALTER C | PRESIDENT, CEO | Grant | A | 0.00 | 24,639 | 0 | 562,432 | 537.8 K to 562.4 K (+4.58 %) |
Nov 19 2013 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | A | 12.91 | 24,000 | 309,840 | 24,000 | |
Aug 09 2013 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Option Exercise | M | 5.87 | 50,000 | 293,500 | 90,000 | |
Aug 09 2013 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Sell | S | 10.01 | 30,000 | 300,354 | 137,270 | 167.3 K to 137.3 K (-17.94 %) |
Aug 09 2013 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Payment of Exercise | F | 9.83 | 29,858 | 293,504 | 167,270 | 197.1 K to 167.3 K (-15.15 %) |
Aug 09 2013 | RGEN | REPLIGEN CORP | RUSCHE JAMES R | Senior Vice Preside ... | Buy | M | 5.87 | 50,000 | 293,500 | 197,128 | 147.1 K to 197.1 K (+33.98 %) |
Jun 21 2013 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Buy | P | 7.70 | 1,000 | 7,700 | 33,880 | 32.9 K to 33.9 K (+3.04 %) |
May 20 2013 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 9.00 | 1,000 | 9,000 | 0 | 1,000 to 0 (-100.00 %) |